- Short genome report
- Open Access
Draft genome sequence of Acinetobacter baumannii strain NCTC 13423, a multidrug-resistant clinical isolate
Standards in Genomic Sciences volume 11, Article number: 57 (2016)
Acinetobacter baumannii is a pathogen that is becoming increasingly important and causes serious hospital-acquired infections. We sequenced the genome of A. baumannii NCTC 13423, a multidrug-resistant strain belonging to the international clone II group, isolated from a human infection in the United Kingdom in 2003. The 3,937,944 bp draft genome has a GC-content of 39.0 % and a total of 3672 predicted protein-coding sequences. The availability of genome sequences of multidrug-resistant A. baumannii isolates will fuel comparative genomic studies to help understand the worrying spread of multidrug resistance in this pathogen.
Acinetobacter baumannii recently emerged as an increasingly important pathogen causing healthcare-associated bloodstream, urinary tract, pulmonary, and device-related infections . A. baumannii strains are often resistant against multiple antibiotics, owing to their high intrinsic resistance and a variety of acquired resistance mechanisms . Carbapenem is usually an effective treatment choice, but carbapenem-resistant strains are globally on the rise, and alternative treatment options are limited .
Here, we present the draft genome sequence of A. baumannii NCTC 13423, a strain belonging to international clone lineage II isolated from a patient in a UK hospital in December 2003 . NCTC 13423 shows resistance to ampicillin, amoxicillin-clavulanic acid, aztreonam, cefepime, cefotaxime, ceftazidime, cefoxitin, piperacillin, piperacillin-tazobactam, ciprofloxacin, gentamicin, and sulbactam . Although originally reported as carbapenem-sensitive, a later report classified it to be also carbapenem-resistant . Additionally, this strain is highly virulent and a strong biofilm producer .
Classification and features
Bacteria in the genus Acinetobacter are Gram-negative, strictly aerobic, nonfermenting, nonmotile, catalase-positive, oxidase-negative coccobacilli  (Table 1). The genus Acinetobacter has gone through many taxonomic changes over the years, and the species A. baumannii has only been officially recognized since 1986 [8, 9]. A. baumannii belongs to the family Moraxellaceae , order Pseudomonadales , class Gammaproteobacteria , and phylum Proteobacteria . Acinetobacter species are ubiquitous organisms, widely distributed in nature, and can be recovered from virtually any soil or water sample. However, A. baumannii seems to be an exception to this rule, as it currently has no known habitats except the hospital . Microscopically, they are often observed as pairs of cells (Fig. 1). A. baumannii can withstand prolonged desiccation, allowing it to survive on dry surfaces and probably contributing to its persistent residence in hospital settings . A phylogenetic tree based on 16S rDNA sequences showed strong clustering with other A. baumannii strains (Fig. 2).
Genome sequencing information
Genome project history
The strain NCTC 13423 was isolated in 2003 in the United Kingdom from a repatriated casualty of the Iraq conflict , and was selected for sequencing because of its multidrug-resistant and virulence characteristics. Sequencing was carried out at the EMBL GeneCore facility (Heidelberg, Germany). Sequences were assembled using CLC Genomics Workbench (version 7.5.1) and annotated using NCBI’s Prokaryotic Genome Annotation Pipeline (PGAP). This draft whole-genome sequence has been deposited at DDBJ/ENA/GenBank under the accession LOHD00000000. The project information, and its association with MIGS version 2.0 , is summarised in Table 2.
Growth conditions and genomic DNA preparation
Cultures for DNA isolation were inoculated from a single colony on LB agar in 5 ml lysogeny broth and grown overnight at 37 °C with orbital shaking (200 rpm). DNA was isolated using the DNeasy Blood&Tissue Kit (Qiagen) following the manufacturer’s instructions and pre-treatment protocol for Gram-negative bacteria. DNA concentration and purity were assessed using the Nanodrop ND-1000 spectrophotometer and Qubit fluorometer (ThermoFisher Scientific).
Genome sequencing and assembly
Sequencing was performed using the Nextera DNA Library Preparation Kit with the Illumina HiSeq 2000 platform (100 bp, paired-end) at the EMBL GeneCore facility (Heidelberg, Germany). The read library contained a total of 8,765,016 sequences in pairs. Sequence data was analysed using Qiagen’s CLC Genomics Workbench (version 7.5.1). First, reads were trimmed for quality (score limit 0.05) and ambiguous nucleotides (maximum 2 ambiguities). Next, de novo assembly was performed (mismatch cost: 2, deletion cost: 3, insertion cost: 3, length fraction: 0.5, similarity fraction: 0.8), yielding 196 contigs (minimum length 200 bp) with an average coverage of 203x. Contigs averaged 20,092 bp in length (N50 of 111,328 bp). The total length of the draft genome is 3,937,944 bp with a GC-content of 39.0 %.
All contigs were annotated using NCBI’s Prokaryotic Genome Annotation Pipeline (PGAP). The Batch Web CD-Search Tool from NCBI  was used to identify Pfam domains  in the predicted protein sequences. Classification of predicted proteins in Clusters of Orthologous Groups (COG) functional categories  was done with the WebMGA web server for metagenomic analysis . Signal peptides, transmembrane domains, and CRISPR repeats were predicted using the SignalP 4.1 server , the TMHMM server , and the CRISPRFinder tool , respectively. Only confirmed and not questionable CRISPR hits were taken into account.
Table 3 summarises the properties of the draft genome. Reads were assembled into 196 contigs, totalling 3,937,944 bp with a 39.0 % GC-content. PGAP predicted a total number of 3875 genes, including 3672 protein coding genes (totalling 3,384,768 base pairs), 135 pseudo genes, and 68 RNA genes (64 tRNA, 3 rRNA, and 1 ncRNA). 75.17 % of the protein-coding genes had a putative function assigned, the remainder was annotated as a hypothetical protein. Additional characteristics of the predicted genes are given in Table 3, and Table 4 shows their distribution amongst the different functional COG categories.
Insights from the genome sequence
Functional analysis of the genome sequence by RAST annotation  revealed A. baumannii ACICU as the closest related sequenced neighbor. A. baumannii ACICU is an epidemic, multidrug-resistant strain isolated from a hospital outbreak in Rome . The high genetic relatedness between A. baumannii ACICU and A. baumannii NCTC 13423 was confirmed by calculating their two-way average amino acid identity (AAI), which was 99.30 % based on 3360 protein sequences . Indicative for the multidrug-resistant phenotype, annotations by RAST included six different β-lactamase enzymes, among which two AmpC-type β-lactamases (class C), a metallo-β-lactamase (class B), two class A β-lactamases (of which one TEM-type broad-spectrum β-lactamase) and an oxa-51 like carbapenemase (class D). Using TAfinder, a web-based tool to identify type II toxin-antitoxin (TA) loci in bacterial genomes , we predicted the presence of 12 type II TA modules in the A. baumannii NCTC 13423 draft genome. Considering only TAfinder hits with normalized homology scores (H-value) > 0.5, five putative TA modules remain, three of which are also present in the genome of A. baumannii ACICU. Interestingly, A. baumannii has been reported to form antibiotic-tolerant persister cells [24, 25], and these TA modules might play a role in their formation .
We determined the draft genome sequence of the highly virulent, multidrug-resistant A. baumannii NCTC 13423 clinical isolate. The availability of genomic sequences of clinical A. baumannii isolates from a variety of locations and sources will benefit comparative genomic studies to better understand the worrying spread of multidrug resistance in this pathogen.
Clusters of orthologous groups
Prokaryotic genome annotation pipeline
Antunes LCS, Visca P, Towner KJ. Acinetobacter baumannii: evolution of a global pathogen. Pathog Dis. 2014;71:292–301.
Potron A, Poirel L, Nordmann P. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology. Int J Antimicrob Agents. 2015;45:568–85.
Viehman JA, Nguyen MH, Doi Y. Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections. Drugs. 2014;74:1315–33.
Turton JF, Kaufmann ME, Gill MJ, Pike R, Scott PT, Fishbain J, et al. Comparison of Acinetobacter baumannii isolates from the United Kingdom and the United States that were associated with repatriated casualties of the Iraq conflict. J Clin Microbiol. 2006;44:2630–4.
Merabishvili M, Vandenheuvel D, Kropinski AM, Mast J, De Vos D, Verbeken G, et al. Characterization of newly isolated lytic bacteriophages active against Acinetobacter baumannii. PLoS One. 2014;9:e104853.
Wand ME, Bock LJ, Turton JF, Nugent PG, Sutton JM. Acinetobacter baumannii virulence is enhanced in Galleria mellonella following biofilm adaptation. J Med Microbiol. 2012;61:470–7.
Towner KJ. Acinetobacter: an old friend, but a new enemy. J Hosp Infect. 2009;73:355–63.
Bouvet PJM, Grimont PAD. Taxonomy of the genus Acinetobacter with the recognition of Acinetobacter baumannii sp. nov., Acinetobacter haemolyticus sp. nov., Acinetobacter johnsonii sp. nov., and Acinetobacter junii sp. nov. and emended descriptions of Acinetobacter calcoaceticus and Acinetobacter lwofii. Int J Syst Bacteriol. 1986;36:228–40.
Chan JZ-M, Halachev MR, Loman NJ, Constantinidou C, Pallen MJ. Defining bacterial species in the genomic era: insights from the genus Acinetobacter. BMC Microbiol. 2012;12:302.
Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21:538–82.
Jawad A, Seifert H, Snelling AM, Heritage J, Hawkey PM. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol. 1998;36:1938–41.
Field D. The minimum information about a genome sequence (MIGS) specification. Nat Biotechnol. 2008;26:541–7.
Marchler-Bauer A, Derbyshire MK, Gonzales NR, Lu S, Chitsaz F, Geer LY, et al. CDD: NCBI’s conserved domain database. Nucleic Acids Res. 2015;43:D222–6.
Finn RD, Coggill P, Eberhardt RY, Eddy SR, Mistry J, Mitchell AL, et al. The Pfam protein families database: towards a more sustainable future. Nucleic Acids Res. 2015;44:D279–85.
Galperin MY, Makarova KS, Wolf YI, Koonin EV. Expanded microbial genome coverage and improved protein family annotation in the COG database. Nucleic Acids Res. 2015;43:D261–9.
Wu S, Zhu Z, Fu L, Niu B, Li W. WebMGA: a customizable web server for fast metagenomic sequence analysis. BMC Genomics. 2011;12:444.
Petersen TN, Brunak S, von Heijne G, Nielsen H. SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods. 2011;8:785–6.
Krogh A, Larsson B, von Heijne G, Sonnhammer EL. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol. 2001;305:567–80.
Grissa I, Vergnaud G, Pourcel C. CRISPRFinder: a web tool to identify clustered regularly interspaced short palindromic repeats. Nucleic Acids Res. 2007;35:52–7.
Overbeek R, Olson R, Pusch GD, Olsen GJ, Davis JJ, Disz T, et al. The SEED and the rapid annotation of microbial genomes using subsystems technology (RAST). Nucleic Acids Res. 2014;42:D206–14.
Iacono M, Villa L, Fortini D, Bordoni R, Imperi F, Bonnal RJP, et al. Whole-genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter baumannii strain belonging to the European clone II group. Antimicrob Agents Chemother. 2008;52:2616–25.
Rodriguez-R LM, Konstantinidis KT. The enveomics collection: a toolbox for specialized analyses of microbial genomes and metagenomes. PeerJ Prepr. 2016;4:e1900v1.
Shao Y, Harrison EM, Bi D, Tai C, He X, Ou HY, et al. TADB: a web-based resource for type 2 toxin-antitoxin loci in bacteria and archaea. Nucleic Acids Res. 2011;39:606–11.
Michiels JE, Van den Bergh B, Verstraeten N, Fauvart M, Michiels J. In vitro emergence of high persistence upon periodic aminoglycoside challenge in the ESKAPE pathogens. Antimicrob Agents Chemother. 2016;60(8):4630–7.
Barth VC, Rodrigues BÁ, Bonatto GD, Gallo SW, Pagnussatti VE, Ferreira CAS, et al. Heterogeneous persister cells formation in Acinetobacter baumannii. PLoS One. 2013;8:e84361.
Maisonneuve E, Gerdes K. Molecular mechanisms underlying bacterial persisters. Cell. 2014;157:539–48.
Edgar RC. MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC Bioinf. 2004;5:113.
Kumar S, Stecher G, Tamura K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016;33:1870–4.
Woese CR, Kandler O, Wheelis ML. Towards a natural system of organisms: proposal for the domains Archaea, Bacteria, and Eucarya. Proc Natl Acad Sci. 1990;87:4576–9.
Garrity G, Bell J, Lilburn T. Phylum XIV. Proteobacteria phyl. nov. In: Brenner DJ, Krieg NR, Staley JT, Garrity GM, editors. Bergey’s manual of systematic bacteriology.Vol 2. New York: Springer; 2005. p. 1.
Garrity G, Bell J, Lilburn T. Class III. Gammaproteobacteria class. nov. In: Brenner DJ, Krieg NR, Staley JT, Garrity GM, editors. Bergey’s manual of systematic bacteriology.Vol 2. New York: Springer; 2005. p. 1.
List editor. Validation of publication of new names and new combinations previously effectively published outside the IJSEM. List no. 106. Int. J. Syst. Evol. Microbiol. 2005;55:2235.
Orla-Jensen S. The main lines of the natural bacterial system. J Bacteriol. 1921;6:263.
Skerman V, McGowan V, Sneath P. Approved lists of bacterial names. Int J Syst Bacteriol. 1980;30:225–420.
Rossau R, Van Landschoot A, Gillis M, De Ley J. Taxonomy of Moraxellaceae fam. nov., a new bacterial family to accommodate the genera Moraxella, Acinetobacter, and Psychrobacter and related organisms. Int J Syst Bacteriol. 1991;41:310–9.
Brisou J, Prévot AR. Études de systématique bactérienne. X. Révision des espèces réunies dans le genre Achromobacter. Ann Inst Pasteur (Paris). 1954;86:722.
Von Graevenitz A. Acinetobacter, Alcaligenes, Moraxella, and other nonfermentative Gram-negative bacteria. In: Murray PR, Barron JE, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. Washington: ASM Press; 1995. p. 520–32.
Visca P, Seifert H, Towner KJ. Acinetobacter infection - an emerging threat to human health. IUBMB Life. 2011;63:1048–54.
Ashburner M, Ball CA, Blake JA. Gene ontology: tool for the unification of biology. Nat Genet. 2000;25:25–9.
JEM and BVDB are recipients of a fellowship from the Agency for Innovation by Science and Technology (IWT) and the Research Foundation Flanders (FWO), respectively. This work was supported by grants from the KU Leuven Research Council (PF/10/010 “NATAR”, IDO/09/01), the Interuniversity Attraction Poles program initiated by the Belgian Science Policy Office (IAP P7/28) and the FWO (grants G.0413.10, G.0471.12 N, G.0B25.15 N). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
JEM performed the experiments, analysed the data, and wrote the manuscript. BVDB and MF helped analysing the data and edited the manuscript. JM initiated and supervised the study, and edited the manuscript. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
About this article
Cite this article
Michiels, J.E., Van den Bergh, B., Fauvart, M. et al. Draft genome sequence of Acinetobacter baumannii strain NCTC 13423, a multidrug-resistant clinical isolate. Stand in Genomic Sci 11, 57 (2016) doi:10.1186/s40793-016-0181-7
- Draft genome
- Acinetobacter baumannii
- Nosocomial pathogen
- Multidrug resistance
- Human isolate